← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

The Hanover Insurance Group, Inc. (THG) 10-Year Financial Performance & Capital Metrics

THG • • Insurance & Managed Care
Financial ServicesProperty & Casualty InsuranceCommercial Lines InsuranceDiversified Commercial Lines
AboutThe Hanover Insurance Group, Inc., through its subsidiaries, provides various property and casualty insurance products and services in the United States. The company operates through three segments: Commercial Lines, Personal Lines, and Other. The Commercial Lines segment offers commercial multiple peril, commercial automobile, and workers' compensation insurance products, as well as management and professional liability, marine, specialty industrial and commercial property, monoline general liability, surety, umbrella, fidelity, crime, and other commercial coverages. The Personal Lines segment provides personal automobile and homeowner's coverages, as well as other personal coverages, such as personal umbrella, inland marine, fire, personal watercraft, personal cyber, and other miscellaneous coverages. The Other segment markets investment management services to institutions, pension funds, and other organizations. The Hanover Insurance Group, Inc. markets its products and services through independent agents and brokers. The company was formerly known as Allmerica Financial Corp. and changed its name to The Hanover Insurance Group, Inc. in December 2005. The Hanover Insurance Group, Inc. was founded in 1852 and is headquartered in Worcester, Massachusetts.Show more
  • Revenue $6.22B +4.2%
  • Combined Ratio 91.35% -8.0%
  • Net Income $426M +1106.8%
  • Return on Equity 16.05% +991.3%
  • Medical Cost Ratio 80.09% -10.1%
  • Operating Margin 8.65% +1155.2%
  • Net Margin 6.85% +1057.6%
  • ROA 2.85% +1055.1%
  • Equity / Assets 18.6% +10.3%
  • Book Value per Share 78.07 +14.3%
  • Tangible BV/Share 73.16 +15.5%
  • Debt/Equity 0.28 -13.1%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Profitable underwriting: 91.3% combined ratio
  • ✓Strong Piotroski F-Score: 7/9
  • ✓Healthy dividend yield of 2.0%

✗Weaknesses

  • ✗High loss ratio of 80.1%

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y2.07%
5Y4.92%
3Y6.41%
TTM5.12%

Profit (Net Income) CAGR

10Y4.21%
5Y0.04%
3Y0.25%
TTM72.65%

EPS CAGR

10Y6.42%
5Y2.27%
3Y0.61%
TTM71.63%

ROCE

10Y Avg2.55%
5Y Avg2.66%
3Y Avg2.04%
Latest4.68%

Peer Comparison

Diversified Commercial Lines
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
SIGISelective Insurance Group, Inc.5.01B82.9725.6914.87%7.78%11.65%21.33%0.16
LLoews Corporation21.32B103.1616.099.96%8.07%7.55%11.22%0.50
WRBW. R. Berkley Corporation26.11B68.7115.7612.32%13.01%19.44%13.68%0.34
THGThe Hanover Insurance Group, Inc.6.05B170.1514.544.25%9.75%18.44%13.15%0.28
CBChubb Limited118.5B301.1113.2612%16.48%12.43%13.66%0.22
CNACNA Financial Corporation12.56B46.4213.196.66%6.84%8.81%19.71%0.28
TRVThe Travelers Companies, Inc.60.53B271.3412.6412.22%12.13%18.58%14.99%0.29
AFGAmerican Financial Group, Inc.11B131.9012.487.12%9.7%16.87%10.47%0.33

Profit & Loss

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Revenue+5.05B3.97B4.27B4.47B4.89B4.82B5.16B5.43B5.96B6.22B
Revenue Growth %-0%-0.21%0.08%0.05%0.1%-0.01%0.07%0.05%0.1%0.04%
Medical Costs & Claims+3.92B3.35B3.42B3.62B3.79B3.8B4.12B4.72B5.31B4.98B
Medical Cost Ratio %----------
Gross Profit+1.13B616M847.6M849.7M1.1B1.02B1.04B716.3M652.9M1.24B
Gross Margin %----------
Gross Profit Growth %0.03%-0.46%0.38%0%0.29%-0.07%0.02%-0.31%-0.09%0.9%
Operating Expenses+691.6M550M554.7M567.2M576.4M577.6M521.4M572.3M611.8M699.9M
OpEx / Revenue %----------
Depreciation & Amortization30.2M30.7M30.1M24.6M21.6M18.2M16.9M12.9M6.3M1.5M
Combined Ratio %----------
Operating Income+439.4M66M292.9M282.5M522.1M444.8M521.3M144M41.1M537.8M
Operating Margin %----------
Operating Income Growth %0.16%-0.85%3.44%-0.04%0.85%-0.15%0.17%-0.72%-0.71%12.09%
EBITDA+469.6M96.7M323M307.1M543.7M463M538.2M156.9M47.4M539.3M
EBITDA Margin %----------
Interest Expense60.6M51.4M45.2M45.1M37.5M37.1M34M34.1M34.1M34.1M
Non-Operating Income-60.6M-51.4M-45.2M-45.1M-37.5M-37.1M-34M-34.1M-34.1M-34.1M
Pretax Income+439.4M66M292.9M282.5M522.1M444.8M521.3M144M41.1M537.8M
Pretax Margin %----------
Income Tax+108.6M-1M76.8M43.5M93.1M82.8M101.3M27.2M7.6M112.5M
Effective Tax Rate %----------
Net Income+331.5M155.1M186.2M391M425.1M358.7M422.8M116M35.3M426M
Net Margin %----------
Net Income Growth %0.18%-0.53%0.2%1.1%0.09%-0.16%0.18%-0.73%-0.7%11.07%
EPS (Diluted)+7.403.594.339.0910.469.4211.493.210.9811.70
EPS Growth %0.18%-0.51%0.21%1.1%0.15%-0.1%0.22%-0.72%-0.69%10.94%
EPS (Basic)7.713.634.389.2411.079.5111.793.210.9811.85
Diluted Shares Outstanding44.8M43.2M43M43M40.6M38.1M36.4M36.1M36.1M36.4M

Balance Sheet

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Assets+13.78B14.22B15.47B12.4B12.49B13.44B14.25B14B14.61B15.27B
Asset Growth %0%0.03%0.09%-0.2%0.01%0.08%0.06%-0.02%0.04%0.05%
Total Investment Assets+7.56B7.92B6.33B12.79B8B8.85B8.39B7.72B425.5M1.59B
Long-Term Investments7.56B7.92B6.33B6.63B7.26B8.05B8.39B7.72B425.5M0
Short-Term Investments0006.16B6.69B7.45B0001.59B
Total Current Assets+4.37B1.72B297.9M6.31B003.61B1.91B2.02B2.24B
Cash & Equivalents338.8M282.6M376.4M1.02B215.7M120.6M230.9M305M316.1M435.5M
Receivables1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Other Current Assets00-1.65B-3.7B-9.98B-10.79B000-1.59B
Goodwill & Intangibles+186M184.8M192.6M178.8M178.8M178.8M178.8M178.8M178.8M178.8M
Goodwill186M184.8M192.6M178.8M178.8M178.8M178.8M178.8M178.8M178.8M
Intangible Assets0000000000
PP&E (Net)0000000000
Other Assets0-7.8B1.86B0-7.44B-8.23B5.27B-7.52B00
Total Liabilities10.94B11.36B12.47B9.45B9.57B10.24B11.11B11.66B12.15B12.43B
Total Debt+803.1M786.4M786.9M777.9M653.4M780.8M781.6M782.4M783.2M784.1M
Net Debt464.3M503.8M410.5M-242.8M437.7M660.2M550.7M477.4M467.1M348.6M
Long-Term Debt803.1M786.4M786.9M777.9M653.4M780.8M781.6M782.4M783.2M722.3M
Short-Term Debt00000000061.8M
Total Current Liabilities+930.1M728M344.8M37.3M0055.1M731.7M6.09B819.6M
Accounts Payable205.2M251.9M51.5M37.3M53.4M48.4M55.1M70.3M64.3M37.7M
Deferred Revenue0000000000
Other Current Liabilities-724.9M-251.9M00-681.1M-735.9M-907.7M-70.3M5.25B-37.7M
Deferred Taxes00001000K1000K0000
Other Liabilities10.13B9.85B11.69B8.67B-705.2M-878.1M10.33B10.16B11.36B10.89B
Total Equity+2.84B2.86B3B2.95B2.92B3.2B3.14B2.33B2.47B2.84B
Equity Growth %0%0%0.05%-0.01%-0.01%0.1%-0.02%-0.26%0.06%0.15%
Shareholders Equity2.84B2.86B3B2.95B2.92B3.2B3.14B2.33B2.47B2.84B
Minority Interest0000000000
Retained Earnings1.8B1.88B1.98B2.18B2.41B2.67B2.98B2.99B2.91B3.21B
Common Stock600K600K600K600K600K600K600K600K600K600K
Accumulated OCI53.9M62.8M107.6M-116.5M152.6M372.5M122.2M-701.5M-517.2M-456.3M
Return on Equity (ROE)0.12%0.05%0.06%0.13%0.14%0.12%0.13%0.04%0.01%0.16%
Return on Assets (ROA)0.02%0.01%0.01%0.03%0.03%0.03%0.03%0.01%0%0.03%
Equity / Assets----------
Debt / Equity0.28x0.28x0.26x0.26x0.22x0.24x0.25x0.34x0.32x0.28x
Book Value per Share63.4966.1569.7168.7171.8384.0586.4064.6568.3078.07
Tangible BV per Share----------

Cash Flow

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+444.7M743.4M704.6M551.3M602.9M707.6M823.7M722.3M361.7M806.4M
Operating CF Growth %-0.21%0.67%-0.05%-0.22%0.09%0.17%0.16%-0.12%-0.5%1.23%
Operating CF / Revenue %----------
Net Income331.5M155.1M186.2M391M425.1M358.7M420M116M35.3M426M
Depreciation & Amortization30.2M30.7M30.1M24.6M21.6M18.2M16.9M12.9M6.3M1.5M
Stock-Based Compensation12.3M12M12.3M13.4M17.4M20.1M22.9M29M31.1M31M
Deferred Taxes53.1M-13.2M39.8M-23.4M12.5M-23M25M-46.5M-24.6M-18.8M
Other Non-Cash Items-36.1M95.9M-37.4M-102.6M-111.1M-17.6M-281.1M49.6M41.5M145.8M
Working Capital Changes53.7M462.9M473.6M248.3M237.4M351.2M620M561.3M272.1M220.9M
Cash from Investing+-171.5M-495.4M-506.3M271.3M-311.9M-608.8M-460.2M-507.6M-228.5M-541.5M
Capital Expenditures-19.5M-15.7M-18.6M-13.1M-13.3M-14.9M-8M-17.8M-11.9M-10.2M
Acquisitions44.3M00635.7M34.7M00000
Purchase of Investments-2.22B-2.37B-1.87B-1.6B-1.92B-2.08B-2.3B-2.08B-1.13B-3.31B
Sale/Maturity of Investments1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Other Investing-1.1M12.1M-9.5M000000-600K
Cash from Financing+-301M-300.8M-111.7M-171M-1.1B-193.9M-253.2M-140.6M-122.1M-145.5M
Dividends Paid-74.2M-80.4M-86.8M-94.3M-386.2M-99.5M-102.2M-108.9M-117.2M-124.1M
Share Repurchases-127.3M-105.6M-37.2M-57.7M-563.6M-212.8M-162.6M-30.8M0-26.7M
Stock Issued0000000000
Debt Issuance (Net)-1000K-1000K0-1000K-1000K1000K0000
Other Financing14.8M-10.1M12.3M-7.4M1.6M-2.2M11.6M-900K-4.9M5.3M
Net Change in Cash+-34.5M-56.2M150.6M722.8M-805M-95.1M110.3M74.1M11.1M119.4M
Exchange Rate Effect-1000K-1000K1000K-1000K1000K00000
Cash at Beginning373.3M338.8M147.3M297.9M1.02B215.7M120.6M230.9M305M316.1M
Cash at End338.8M282.6M297.9M1.02B215.7M120.6M230.9M305M316.1M435.5M
Free Cash Flow+418.9M721.9M686M538.2M589.6M692.7M815.7M704.5M349.8M796.2M
FCF Growth %-0.24%0.72%-0.05%-0.22%0.1%0.17%0.18%-0.14%-0.5%1.28%
FCF Margin %----------
FCF per Share9.3516.7115.9512.5214.5218.1822.4119.529.6921.87

Key Ratios

Metric2015201620172018201920202021202220232024
Combined Ratio91.3%98.34%93.14%93.67%89.32%90.77%89.9%97.35%99.31%91.35%
Medical Cost Ratio77.6%84.47%80.14%80.97%77.54%78.78%79.79%86.82%89.05%80.09%
Return on Equity (ROE)11.66%5.44%6.36%13.14%14.48%11.73%13.32%4.23%1.47%16.05%
Return on Assets (ROA)2.41%1.11%1.25%2.81%3.42%2.77%3.05%0.82%0.25%2.85%
Equity / Assets20.64%20.09%19.38%23.83%23.35%23.82%22.06%16.68%16.87%18.6%
Book Value / Share63.4966.1569.7168.7171.8384.0586.464.6568.378.07
Debt / Equity0.28x0.28x0.26x0.26x0.22x0.24x0.25x0.34x0.32x0.28x
Revenue Growth-0.38%-21.45%7.62%4.64%9.51%-1.47%7.08%5.3%9.77%4.25%

Revenue by Segment

2015201620172018201920202021202220232024
Personal Lines--1.58B1.71B1.82B1.84B1.93B2.11B2.44B2.56B
Personal Lines Growth---7.92%6.70%1.31%4.63%9.51%15.59%5.00%
Core Commercial Lines-------1.95B2.22B2.32B
Core Commercial Lines Growth--------13.65%4.84%
Specialty Lines-------1.19B1.35B1.41B
Specialty Lines Growth--------13.68%4.49%
Other Operating---------12.4M
Other Operating Growth----------
Others--------15.4M-
Others Growth----------
Commercial Lines--2.4B2.55B2.65B2.68B2.84B---
Commercial Lines Growth---6.20%4.15%1.10%5.87%---
All Others----26M-----
All Others Growth----------
Other Property And Casualty---14.2M------
Other Property And Casualty Growth----------
Chaucer1.05B838.6M853M-------
Chaucer Growth--20.22%1.72%-------
Property Liability And Casualty Insurance3.65B3.79B--------
Property Liability And Casualty Insurance Growth-3.72%--------

Frequently Asked Questions

Valuation & Price

The Hanover Insurance Group, Inc. (THG) has a price-to-earnings (P/E) ratio of 14.5x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

The Hanover Insurance Group, Inc. (THG) grew revenue by 4.2% over the past year. Growth has been modest.

Yes, The Hanover Insurance Group, Inc. (THG) is profitable, generating $631.9M in net income for fiscal year 2024 (6.9% net margin).

Dividend & Returns

Yes, The Hanover Insurance Group, Inc. (THG) pays a dividend with a yield of 2.00%. This makes it attractive for income-focused investors.

The Hanover Insurance Group, Inc. (THG) has a return on equity (ROE) of 16.1%. This is reasonable for most industries.

Industry Metrics

The Hanover Insurance Group, Inc. (THG) has a combined ratio of 91.3%. A ratio below 100% indicates underwriting profitability.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.